Docs of the Month: Top 5 in a Summer of Medtech Policymaking
China builds frameworks for brain-computer interface implantables, generative AI gets FDA and MHRA attention, and three more key medtech policy focus areas in July and August.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
China builds frameworks for brain-computer interface implantables, generative AI gets FDA and MHRA attention, and three more key medtech policy focus areas in July and August.
This month, consumer tech giants acquire or partner to put core skill sets to use for medical applications; two private equity deals signal what's hot; and Curium, curiously, creates a radiopharmaceuticals giant.
New funding from for the agency’s ADVOCATE program. Excerpted from Pathways Picks September 9: FDA Taps Tech Chief, Key Staffer Departs, EU Procurement Reform, and More.